GlassScriptPhysician profile
Ryan Alan Vincent
NPI 1376986604
$7,491.65
in general payments reported to CMS, 2019-2025
29 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,866 · 2020: $577 · 2021: $573 · 2022: $264 · 2023: $1,369 · 2024: $257 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616 · Travel and Lodging: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.19 |
| Travel and Lodging | $595.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,468.01 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,170.88 | 2019-2023 | Senza |
| Vertiflex, INC. | $845.36 | 2019 | |
| Boston Scientific Corporation | $801.85 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $769.40 | 2023 | Iovera, Zilretta |
| Medtronic, INC. | $263.99 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Relievant Medsystems, INC. | $151.22 | 2023 | Intracept |
| Sirtex Medical INC | $141.97 | 2023 | Sir-Spheres Microspheres |
| Averitas Pharma INC. | $140.48 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $96.25 | 2020-2021 | |
| Pacira Therapeutics, INC. | $88.73 | 2020-2021 | |
| Grt US Holding, INC. | $65.98 | 2021-2022 | |
| Forte Bio-Pharma LLC | $61.34 | 2024 | Prolate, Nalocet |
| Arbor Pharmaceuticals, INC. | $54.66 | 2019-2021 | |
| Protega Pharmaceutials INC | $40.72 | 2025 | Roxybond |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $40.18 | 2023 | Sprint Pns System |
| Saluda Medical Americas, INC. | $38.90 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic USA, INC. | $35.73 | 2019 | |
| Globus Medical, INC. | $29.67 | 2025 | Senza |
| Amgen INC. | $27.62 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $22.97 | 2020 | |
| Curonix LLC | $21.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $20.04 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.79 | 2025 | |
| Azurity Pharmaceuticals, INC. | $19.05 | 2025 | Horizant |
| Horizon Therapeutics Plc | $15.50 | 2022 | |
| Almatica Pharma LLC | $15.37 | 2021 | |
| Nalu Medical, INC. | $13.64 | 2023 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Vincent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.